- •
Remodeling changes in eosinophilic esophagitis include epithelial basal zone hyperplasia, lamina propria fibrosis, expansion of the muscularis propria, and increased vascularity.
- •
Esophageal inflammation in eosinophilic esophagitis drives the remodeling process with mediators that include IL-5, IL-13, TGFβ1, mast cells, fibroblasts, and eosinophils.
- •
Recent studies have provided increasing evidence that the primary symptoms of esophageal dysfunction in children and adults as well as clinical
Clinical Implications and Pathogenesis of Esophageal Remodeling in Eosinophilic Esophagitis
Section snippets
Key points
Definition of esophageal remodeling
The concept of eosinophil-associated tissue remodeling stems from diseases such as the hypereosinophilic syndrome and asthma. Remodeling can be defined as tissue changes in target organs that result in end organ dysfunction. Remodeling is associated with histologic alterations, such as fibrosis and angiogenesis, which are caused by changes in cellular function, phenotype, and products. Remodeling itself may not be a pathogenic process, as it could be considered to represent a protective
Pathogenesis of esophageal remodeling in EoE
Inflammatory mediators and cells clearly play a role in driving esophageal remodeling (Table 1, Fig. 2). Animal models demonstrate that mice lacking eosinophils or the eosinophilopoetic cytokine interleukin (IL)-5, have significantly less collagen deposition and fibronectin expression than their wild-type littermates.4, 5 In addition, mice that have decreased esophageal eosinophils also have decreased basal zone hyperplasia.5 Importantly, a lack of eosinophils, even in the presence of IL-5
Relationship of esophageal remodeling with clinical manifestations and complications
The clinical presentations of EoE reflect esophageal dysfunction. These functional changes in the esophagus likely reflect esophageal remodeling. In adults, EoE is dominated by symptoms of dysphagia and food impaction, whereas in children symptoms more commonly mimic gastroesophageal reflux disease (GERD) with dysphagia and food impactions becoming more prominent in adolescence. In adult subjects, there are 2 determinants for esophageal food impaction risk: (1) a reduction in luminal diameter
Barium Radiography
A variety of methods have been used in clinical practice and investigative studies to demonstrate the remodeling consequences of EoE (Table 2). One of the oldest methods to evaluate the structure of the gastrointestinal tract is barium radiography. Early case series demonstrated the association of marked restriction of the esophageal luminal caliber with EoE, characterized as a narrow caliber or small-caliber esophagus.32 Fig. 4 illustrates the diffuse nature of this finding. The multiple,
Effectiveness of available therapies for remodeling in EoE
EoE therapies are rapidly evolving as the mechanisms underlying the disease become better understood. Most drugs are in the early stages of development and none are currently approved by regulatory authorities for use in patients outside of clinical trials. Elimination diet therapy has demonstrated effectiveness similar to medical therapies in terms of resolution of mucosal eosinophilic inflammation. The primary end points used to judge the efficacy of therapies are symptoms and esophageal
References (74)
- et al.
Eosinophilic esophagitis: updated consensus recommendations for children and adults
J Allergy Clin Immunol
(2011) - et al.
Esophageal remodeling develops as a consequence of tissue specific IL-5-induced eosinophilia
Gastroenterology
(2008) - et al.
Esophageal remodeling in pediatric eosinophilic esophagitis
J Allergy Clin Immunol
(2007) Mechanism of eosinophilic esophagitis
Immunol Allergy Clin North Am
(2009)- et al.
Subepithelial collagen deposition, profibrogenic cytokine gene expression, and changes after prolonged fluticasone propionate treatment in adult eosinophilic esophagitis: a prospective study
J Allergy Clin Immunol
(2011) - et al.
Eosinophilic esophagitis: epithelial mesenchymal transition contributes to esophageal remodeling and reverses with treatment
J Allergy Clin Immunol
(2012) - et al.
Mast cells infiltrate the esophageal smooth muscle in patients with eosinophilic esophagitis, express TGF-beta1, and increase esophageal smooth muscle contraction
J Allergy Clin Immunol
(2010) - et al.
Involvement of mast cells in eosinophilic esophagitis
J Allergy Clin Immunol
(2010) - et al.
Expression of mast cell-associated genes is upregulated in adult eosinophilic esophagitis and responds to steroid or dietary therapy
J Allergy Clin Immunol
(2011) - et al.
IL-13 involvement in eosinophilic esophagitis: transcriptome analysis and reversibility with glucocorticoids
J Allergy Clin Immunol
(2007)
Periostin facilitates eosinophil tissue infiltration in allergic lung and esophageal responses
Mucosal Immunol
High-resolution EUS in children with eosinophilic “allergic” esophagitis
Gastrointest Endosc
TGF-beta1: mediator of a feedback loop in eosinophilic esophagitis—or should we really say mastocytic esophagitis?
J Allergy Clin Immunol
Patchy eosinophil distributions in an esophagectomy specimen from a patient with eosinophilic esophagitis: implications for endoscopic biopsy
J Allergy Clin Immunol
The small-caliber esophagus: an unappreciated cause of dysphagia for solids in patients with eosinophilic esophagitis
Gastrointest Endosc
Therapeutic end points in eosinophilic esophagitis: is elimination of esophageal eosinophils enough?
Clin Gastroenterol Hepatol
Dilation in eosinophilic esophagitis: to do or not to do?
Gastrointest Endosc
Mechanical properties of the esophagus in eosinophilic esophagitis
Gastroenterology
Esophageal diameter is decreased in some patients with eosinophilic esophagitis and might increase with topical corticosteroid therapy
Clin Gastroenterol Hepatol
EUS and histopathologic correlates in eosinophilic esophagitis
Gastrointest Endosc
The prevalence and diagnostic utility of endoscopic features of eosinophilic esophagitis: a meta-analysis
Clin Gastroenterol Hepatol
Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis?
Gastrointest Endosc
Relationships between eosinophilic inflammation, tissue remodeling, and fibrosis in eosinophilic esophagitis
Immunol Allergy Clin North Am
A symptom scoring tool for identifying pediatric patients with eosinophilic esophagitis and correlating symptoms with inflammation
Ann Allergy Asthma Immunol
Esophageal distensibility as a measure of disease severity in patients with eosinophilic esophagitis
Clin Gastroenterol Hepatol
Long-term budesonide maintenance treatment is partially effective for patients with eosinophilic esophagitis
Clin Gastroenterol Hepatol
Eosinophilic gastroenteritis with esophageal involvement
Gastroenterology
Eosinophilic esophagitis in a patient with vigorous achalasia
Gastroenterology
Achalasia with dense eosinophilic infiltrate responds to steroid therapy
Clin Gastroenterol Hepatol
A randomized, double-blind, placebo-controlled trial of fluticasone propionate for pediatric eosinophilic esophagitis
Gastroenterology
Successful treatment of eosinophilic esophagitis with ciclesonide
J Allergy Clin Immunol
Working with the US Food and Drug Administration: progress and timelines in understanding and treating patients with eosinophilic esophagitis
J Allergy Clin Immunol
Swallowed fluticasone improves histologic but not symptomatic response of adults with eosinophilic esophagitis
Clin Gastroenterol Hepatol
Glucocorticoid-regulated genes in eosinophilic esophagitis: a role for FKBP51
J Allergy Clin Immunol
Molecular diagnosis of eosinophilic esophagitis by gene expression profiling
Gastroenterology
An antibody against IL-5 reduces numbers of esophageal intraepithelial eosinophils in children with eosinophilic esophagitis
Gastroenterology
Siglec-8 as a drugable target to treat eosinophil and mast cell-associated conditions
Pharmacol Ther
Cited by (95)
Real-World Efficacy of Dupilumab in Severe, Treatment-Refractory, and Fibrostenotic Patients With Eosinophilic Esophagitis
2024, Clinical Gastroenterology and HepatologyEndoscopic Features of Eosinophilic Gastrointestinal Diseases
2024, Immunology and Allergy Clinics of North AmericaEndoscopic Ultrasound Can Measure Esophageal Remodeling in Eosinophilic Esophagitis
2024, Techniques and Innovations in Gastrointestinal EndoscopyWhy so Many Patients With Dysphagia Have Normal Esophageal Function Testing
2024, Gastro Hep AdvancesA Newly Proposed Severity Index for Eosinophilic Esophagitis is Associated With Baseline Clinical Features and Successful Treatment Response
2023, Clinical Gastroenterology and HepatologyEosinophilic Esophagitis: A Review for the Primary Care Practitioner
2023, Primary Care - Clinics in Office Practice